Lentiviral vector services for in vivo gene therapies – flexible manufacturing options for the next wave of cell and gene therapies

Combining our deep preclinical development to commercial-stage expertise with the flexibility to engineer precise target-specific therapies to enable durable and stable gene delivery in vivo. As in vivo programs accelerate, our lentiviral vector manufacturing platforms offer a compelling path to the clinic with sustained expression and scalable manufacturing.

Multiple ways to advance your in vivo program

Tech transfer in your own process

Develop your pseudotype-specific platform using our processes

Become a development partner for our new internal pseudotype platform

Benefits of working with us

Commercial experience – fully enabled commercial facility with robust quality systems and experience bringing vector programs to market.
Process flexibility – modular platform approach with multi-pseudotype application enabling high-throughput technical transfer.
Science founded & science led – proactively innovating to remove roadblocks in in vivo development before they arise.

Tech transfer of viral vector production process

What does it look like to work with us?

Tech transfer in

Bring us your vector process at any point in development, from preclinical to commercial.
We will jointly define a tech transfer plan that meets your project priorities.

We will optimize, compare, and implement your process in GMP manufacturing.

Evaluate your pseudotype
in our platform

Utilize the Miltenyi Bioindustry proven process platform to accelerate your in vivo program pathway.
Leverage our deep in-house analytical development expertise.

We will verify the level of platform fit and optimize for pseudotype-specific performance.

Become a development partner
for our internal platform

Novel cell selective vector platform in development with capabilities for improved targeting specificity.

Gain early access to cutting edge technology as a development partner to apply this novel platform to your target.

Questions? Want to know more?
Fill out our form to get in touch with our experts.

Contact us

Privacy Settings